| Autor: |
Mohamed Elboraey, MD, Beau B. Toskich, MD, Andrew R. Lewis, MD, Charles A. Ritchie, MD, Gregory T. Frey, MD, MPH, Zlatko Devcic, MD |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 7, Iss 3, Pp 454-457 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2468-4287 |
| DOI: |
10.1016/j.jvscit.2021.05.006 |
| Popis: |
The use of a Viabahn VBX endoprosthesis (W. L. Gore & Associates, Flagstaff, Ariz) to exclude chronically thrombosed inferior vena cava (IVC) filters refractory to exclusion with self-expanding stents was evaluated. The mean duration of TrapEase IVC (Cordis, Milpitas, Calif) implantation was 7.6 years (range, 2-11 years). Symptoms included leg pain, edema, color changes, and back pain. The mean Villalta score and venous clinical severity score were 17 (range, 13-23) and 13 (range, 11-15), respectively. Indirect ultrasound evidence of stent patency was demonstrated at a mean of 8 months after intervention. The mean Villalta score and venous clinical severity score had decreased by 13 and 10, respectively, at a mean of 9.5 months after intervention. Iliocaval reconstruction with Viabahn VBX balloon expandable stent-graft exclusion of chronically thrombosed TrapEase IVC filters is safe, with favorable short-term results. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
